Health Sciences Group, Inc. (OTCBB:HESG), provider of innovative nutraceutical products and functional food ingredients derived from natural sources, today announced the launch of a new website for its Swiss Diet Shugr(TM) The new website -- located at www.shugr.com -- offers visitors comprehensive information on Shugr(TM) and its ingredients as well as other information offering tips for healthy eating and living. The website will be updated regularly to reflect the latest list of Shugr(TM) retailers as well as news and information on specials and new product offerings. Shugr(TM), a zero-calorie, low glycemic sweetener that tastes and measures like table sugar, is made from sugars that occur naturally in such good-tasting, healthy foods such as fruits, vegetables, corn and dairy products. Erythritol is a naturally-occurring sugar commonly found in melon, grapes, mushrooms and soy. Tagatose comes from dairy products, but does not affect people who are lactose intolerant. Tagatose also provides an added health benefit -- prebiotic fiber that promotes intestinal health, much the way yogurt does. Maltodextrin is derived from corn sugar, which is non-GMO and gluten-free. A trace amount of sucralose is added to give Shugr its "high note." All of these ingredients carry a GRAS (Generally Recognized As Safe) designation for food safety from the US Food & Drug Administration. About Health Sciences Group, Inc. Health Sciences Group identifies, develops and commercializes innovative nutraceutical products derived from natural sources to provide consumers and medical professionals with preventative healthcare alternatives. The company markets its own line of proprietary products based on novel technologies with clinically-supported, GRAS-certified ingredients. For more information, visit www.HealthSciencesGroup.com, www.Sequesterol.com and www.Shugr.com. This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although the Company believes that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, it can give no assurance that such expectations and assumptions will prove to have been correct. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including without limitation, the independent authority of the special committee to act on the matters discussed, the successful negotiation of the potential acquisition and disposal of transactions described above, successful implementation of the company's business strategy and competition, any of which may cause actual results to differ materially from those described in the statements. In addition, other factors that could cause actual results to differ materially are discussed in the Company's most recent Form 10-QSB and Form 10-KSB filings with the Securities and Exchange Commission.
Health Sciences (CE) (USOTC:HESG)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025 Health Sciences (CE) 차트를 더 보려면 여기를 클릭.
Health Sciences (CE) (USOTC:HESG)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025 Health Sciences (CE) 차트를 더 보려면 여기를 클릭.